First to marketIt is amazing the amount of companies looking for a viable treatment in the bladder cancer field. One I was looking at tonight was VAX014 which shows early promise in mice and the company is currently recruiting for a phase1 trial with patients. I don't have the time to go thru all the trials listed on the FDA site but it would be interesting to know how much real competition in this field we have. I hope TLT actually starts phase 2 this quarter and we become the first to market with the best treatment for NMIBC. I picked up a few more shares so it is now like being in the army....hurry up and wait.